Perfluorohexane-loaded macrophages as a novel ultrasound contrast agent: a feasibility study

Liselotte M Kornmann1, Daniëlle M J Curfs, Evelien Hermeling

  • 1Department of Biophysics, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, P. O. Box 616, 6200 MD, Maastricht, The Netherlands.

Abstract

Insights

Perfluorohexane (PFH) loaded macrophages show potential as targeted ultrasound contrast agents. These PFH-loaded macrophages enhance echogenicity for noninvasive imaging of arterial hotspots.

Area of Science:

  • Biomedical Engineering
  • Cell Biology
  • Medical Imaging

Background:

  • Macrophages play a crucial role in inflammatory processes.
  • Targeted molecular imaging aims to enhance diagnostic accuracy.
  • Ultrasound imaging offers a noninvasive visualization method.

Purpose of the Study:

  • To evaluate macrophages as targeted carriers for ultrasound molecular imaging.
  • To investigate the feasibility of using perfluorohexane (PFH) emulsions for this purpose.

Main Methods:

  • Murine bone marrow-derived macrophages (BMM) were incubated with varying concentrations of PFH emulsions.
  • Microscopy, flow cytometry, and ultrasound were used for monitoring.
  • Adhesion molecule expression and endothelial cell adhesion were analyzed.

Main Results:

  • PFH loading led to dose-dependent uptake and increased echogenicity in BMM.
  • No significant down-regulation of BMM adhesion molecules was observed.
  • While adhesion remained functional, PFH loading dose-dependently attenuated static adhesion.

Conclusions:

  • PFH-loaded BMM demonstrate potential as ultrasound contrast agents.
  • This approach may enable noninvasive detection of atherogenic hotspots in arteries.

Related Concept Videos